Merkel Cell Carcinoma
This article or area is currently under construction and may only be partially complete. Please come back soon to see the finished work! (29/12/2023)
Introduction[edit | edit source]
Merkel Cell Carcinoma (MCC) is a rare and aggressive skin cancer typically seen on the facial skin and extremities of elderly Caucasians and immunocompromised people. This neuroendocrine carcinoma accounts for less than 1% of all cutaneous malignancies and is associated with UV exposure and infection with the Merkel cell polyomavirus (MCPyV).[1][2][3]
Epidemiology[edit | edit source]
Aetiology[edit | edit source]
Mechanism of Injury / Pathological Process[edit | edit source]
add text here relating to the mechanism of injury and/or pathology of the condition
Clinical Presentation[edit | edit source]
add text here relating to the clinical presentation of the condition
Diagnostic Procedures[edit | edit source]
add text here relating to diagnostic tests for the condition
Outcome Measures[edit | edit source]
add links to outcome measures here (see Outcome Measures Database)
Management / Interventions
[edit | edit source]
add text here relating to management approaches to the condition
Differential Diagnosis
[edit | edit source]
add text here relating to the differential diagnosis of this condition
Resources
[edit | edit source]
add appropriate resources here
References[edit | edit source]
- ↑ Gauci ML, Aristei C, Becker JC, Blom A, Bataille V, Dreno B, Del Marmol V, Forsea AM, Fargnoli MC, Grob JJ, Gomes F. Diagnosis and treatment of Merkel cell carcinoma: European consensus-based interdisciplinary guideline–Update 2022. European Journal of Cancer. 2022 Aug 1;171:203-31.
- ↑ Zwijnenburg EM, Lubeek SF, Werner JE, Amir AL, Weijs WL, Takes RP, Pegge SA, van Herpen CM, Adema GJ, Kaanders JH. Merkel cell carcinoma: New trends. Cancers. 2021 Mar 31;13(7):1614.
- ↑ Walsh NM, Cerroni L. Merkel cell carcinoma: A review. Journal of Cutaneous Pathology. 2021 Mar;48(3):411-21.